Opaleye Management Inc. 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:31 am Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 1,825,000 5.320% |
143,846 (+8.56%) |
Filing |
| 2024-11-18 06:01 am Purchase |
2024-09-30 | 13G | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 1,681,154 8.150% |
1,681,154 (New Position) |
Filing |